Postsurgical hypoparathyroidism-Risk of fractures, Psychiatric Diseases, Cancer, Cataract, and Infections

Journal of Bone and Mineral Research

Volumn 29, Issue 11 S1, 2014, Pages 2504-2510

  Underbjerg, Line ^a   Sikjaer, Tanja ^a   Mosekilde, Leif ^a   Rejnmark, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Other therapeutics; Parathyroid Related disorders

Indexed keywords

CALCIUM; ALFACALCIDOL; LEVOTHYROXINE; MAGNESIUM; VITAMIN D DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARM FRACTURE; ARTICLE; BIPOLAR DISORDER; BREAST CANCER; CALCIUM INTAKE; CANCER RISK; CATARACT; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; FEMALE; FEMUR FRACTURE; FOLLOW UP; FOREARM FRACTURE; FRACTURE; HOSPITALIZATION; HUMAN; HUMERUS FRACTURE; HYPOPARATHYROIDISM; INFECTION; INFECTION RISK; LEG FRACTURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MENTAL DISEASE; PELVIS FRACTURE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SPINE FRACTURE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTEBRAL CANAL STENOSIS; BIPOLAR DEPRESSION; RANDOMIZED CONTROLLED TRIAL; REGISTER; VERY ELDERLY; CLINICAL TRIAL; DENMARK; FRACTURES, BONE; NECK; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SURGERY;

CATARACT; DENMARK; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FRACTURES, BONE; HUMANS; HYPOPARATHYROIDISM; INFECTION; MALE; NECK; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RISK FACTORS;

EID: 84906695034     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2273     Document Type: Article

References (37)

1. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391-403.
2. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343(25):1863-75.
3. Bergenfelz AF, Jansson S, Kristoffersson AF, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Scandinavian Quality Register for Thyroid and Parathyroid Surgery: audit of surgery for primary hyperparathyroidism.(1435-2451 (Electronic)).
4. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236(5): 543-51.
5. Rosato LF, Avenia NF, Bernante PF, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patien
6. Poole KE, Reeve J. Parathyroid hormone - a bone anabolic and catabolic agent. Current Opinion in Pharmacology. 2005 Dec;5(6): 612-7.
7. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 1982 Jun;69(6):1302-9.
8. Abugassa S, Nordenstrom J, Eriksson S, Sjoden G. Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab. 1993 Jun;.76(6):1617-21.
9. Bilezikian J, Khan A, Potts J Jr, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26:2317-37.
10. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277-85.
11. Arlt W, Fremerey C, Callies F, et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol. 2002 Feb;146(2):215-22.
12. Cusano NE, Rubin MR, McMahon DJ, et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab. 2013 Jun;98(6):2356-61.
13. Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD, Ruan DT. Surgeons and patients disagreeon the potential consequences from hypoparathyroidism. Endocr Pract. 2013 Dec10:1-37.
14. Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008 Jan; 24(1):139-49.
15. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012 Jun;33(3):456-92.
16. McCarty MF. Parathyroid hormone may be a cancer promoter-an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses. 2000 Mar;54(3):475-82.
17. Sandler RS. Calcium supplements to prevent colorectal adenomas. Am J Gastroenterol. 2005 Feb;100(2):395-6.
18. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3): 266-81.
19. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013.
20. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999 Jun;46(3):263-8.
21. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol. 1992 May 1;135(9):1019-28.
22. Velasco PJ, Manshadi M, Breen K, Lippmann S. Psychiatric aspects of parathyroid disease. Psychosomatics. 1999 Nov;40(6):486-90.
23. Bohrer T, Krannich JH. Depression as a manifestation of latent chronic hypoparathyroidism. World J Biol Psychiatry. 2007;8(1):56-9.
24. Lawlor BA. Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry. 1988 Aug;49(8):317-8.
25. Sikjaer T, Rejnmark L, Thomsen JS, et al. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res. 2012 Apr;.27(4):781-8.
26. Takamura Y, Miyauchi A, Yabuta T, Kihara M, Ito Y, Miya A. Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy. World J Surg. 2013 Sep 18.
27. Fujiyama K, Kiriyama T, Ito M, et al. Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab. 1995 Jul;80(7):2135-8.
28. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research. J Bone Miner Res. 2014;29:1-23.
29. Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000 Jun;66(6):419-24.
30. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug; (158):1-235.
31. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985 Feb 9;1(8424): 307-9.
32. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol. 1993 Jun 15;137(12):1302-17.
33. Kearney J, Giovannucci E, Rimm EB, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol. 1996 May 1;143(9):907-17.
34. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010;340:b5500.
35. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010 Sep 1;202(5):809-14.
36. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012 Oct 3;308(13):1333-9.
37. Geara AS, Castellanos MR, Bassil C, et al. Effects of parathyroid hormone on immune function. Clin Dev Immunol. 2010;2010.